127 related articles for article (PubMed ID: 26101473)
1. Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma.
Jin G; Wang M; Chen W; Shi W; Yin J; Gang W
Pak J Med Sci; 2015; 31(2):269-73. PubMed ID: 26101473
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.
Zhou J; Liu ZY; Li CB; Gao S; Ding LH; Wu XL; Wang ZY
Tumour Biol; 2015 Apr; 36(4):3017-23. PubMed ID: 25542228
[TBL] [Abstract][Full Text] [Related]
3. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract][Full Text] [Related]
4. Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer.
Ding C; Zhang H; Chen K; Zhao C; Gao J
Oncol Lett; 2015 Oct; 10(4):1997-2002. PubMed ID: 26622786
[TBL] [Abstract][Full Text] [Related]
5. Genetic Association between ERCC2, NBN, RAD51 Gene Variants and Osteosarcoma Risk: a Systematic Review and Meta-Analysis.
Mehdinejad M; Sobhan MR; Mazaheri M; Zare Shehneh M; Neamatzadeh H; Kalantar SM
Asian Pac J Cancer Prev; 2017 May; 18(5):1315-1321. PubMed ID: 28610420
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract][Full Text] [Related]
9. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
Cao ZH; Yin HP; Jiang N; Yu B
Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951
[TBL] [Abstract][Full Text] [Related]
10. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
12. Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma.
Goričar K; Kovač V; Jazbec J; Lamovec J; Dolžan V
J Med Biochem; 2015 Apr; 34(2):200-206. PubMed ID: 28356832
[TBL] [Abstract][Full Text] [Related]
13. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
[TBL] [Abstract][Full Text] [Related]
14. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA repair gene polymorphisms in glioblastoma.
Rodriguez-Hernandez I; Perdomo S; Santos-Briz A; Garcia JL; Gomez-Moreta JA; Cruz JJ; Gonzalez-Sarmiento R
Gene; 2014 Feb; 536(1):79-83. PubMed ID: 24325908
[TBL] [Abstract][Full Text] [Related]
16. Association between common polymorphisms in
Li C; Yu X; Guo D; Liu G; Zhang K; Teng Q; Lin H
Onco Targets Ther; 2018; 11():3495-3504. PubMed ID: 29950854
[TBL] [Abstract][Full Text] [Related]
17. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
[TBL] [Abstract][Full Text] [Related]
18. Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population.
Xu Q; Zhang Z; Sun W; Hu B
Mamm Genome; 2017 Jun; 28(5-6):227-233. PubMed ID: 28474168
[TBL] [Abstract][Full Text] [Related]
19. Association Between
Boldrin E; Malacrida S; Rumiato E; Battaglia G; Ruol A; Amadori A; Saggioro D
Front Oncol; 2019; 9():85. PubMed ID: 30847299
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
